Navigation Links
Mass Biologic Labs/UMass Med School and Medarex license C. difficile monoclonal antibody to Merck
Date:4/21/2009

WHITEHOUSE STATION N.J., PRINCETON, N.J. and JAMAICA PLAIN, Mass., April 21, 2009 Merck & Co., Inc., (through an affiliate), Medarex, Inc. (NASDAQ: MEDX) and Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) today announced that they have signed an exclusive worldwide license agreement for CDA-1 and CDB-1 (also known as MDX-066/MDX-1388 and MBL-CDA1/MBL-CDB1), an investigational fully human monoclonal antibody combination developed to target and neutralize Clostridium difficile toxins A and B, for the treatment of C. difficile infection (CDI). CDA-1 and CDB-1 were co-developed by Medarex and MBL.

Under the terms of the agreement, Merck gains worldwide rights to develop and commercialize CDA-1 and CDB-1. Medarex and MBL will receive an upfront payment of $60 million and are potentially eligible to receive additional cash payments up to $165 million upon achievement of certain milestones associated with the development and approval of a drug candidate covered by this agreement. Upon commercialization, Medarex and MBL will also be eligible to receive double-digit royalties on product sales and milestones if certain sales targets are met. In accordance with the co-development agreement between Medarex and MBL, all payments will be divided equally.

The incidence of C. difficile infection (CDI) in the U.S. is rapidly increasing, with rates doubling from 2000 to 2005. The Centers for Disease Control and Prevention has projected that there will be as many as 750,000 cases of CDI per year by 2010 .

"C. difficile infection is the primary cause of infectious diarrhea in hospitalized elderly patients in developed countries," said Tony Ford-Hutchinson, Ph.D., senior vice president and franchise head, Infectious Diseases and Vaccines, Merck Research Laboratories. "This agreement underscores Merck's ongoing commitment to infectious disease and our strategy of licens
'/>"/>

Contact: Mark Shelton
mark.shelton@umassmed.edu
508-856-2000
University of Massachusetts Medical School
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. Keck Foundation funds study of biological interactions with nanomaterials
2. New insight into the mechanisms of voltage sensing and transduction in biological processes
3. Biological warfare: What do you need to know?
4. A mechanism to explain biological cross-talk between 24-hour body cycle and metabolism
5. Story ideas from the Journal of Biological Chemistry
6. Emerging field of neuroecology is showcased in December issue of the Biological Bulletin
7. Story ideas from the Journal of Biological Chemistry
8. Systems biologist finds novel solutions to fundamental biological problems
9. MIT applies engineering approach to studying biological pathways
10. Lensless camera uses X-rays to view nanoscale materials and biological specimens
11. Systems biology approach identifies nutrient regulation of biological clock in plants

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...has long held secrets of the earth,s history locke... been very little information on the environments ...lions of years. Now, a team of researchers from ni...o the tune of $10 million dollars by the National ...f things literally. These scientists will drill t...
(Date:11/23/2009)...sents strong evidence that the "synergistic" effec...elated pollution and indoor endotoxin causes more ...osure alone. , Environmental health scientists...edicine have shown that children exposed to both h... endotoxin during early life are six times more li...
(Date:11/23/2009)...ife Conservation Society says that western lowland...of Congopart of the "mother lode" of more than 125...reasingly threatened by growing humans activity in...f the swamp forests adjacent to the southwest bord...s confirmed that high densities of the great apes ...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Affitech Appoints Dr Robert Burns as CEO and Dr Alexander Duncan as SVP Research 26 Development 13756 1Affitech Appoints Dr Robert Burns as CEO and Dr Alexander Duncan as SVP Research 26 Development 13756 2Affitech Appoints Dr Robert Burns as CEO and Dr Alexander Duncan as SVP Research 26 Development 13756 3Jacobs Receives Contract for San Francisco General Hospital and Trauma Center Rebuild Program 55823 1Jacobs Receives Contract for San Francisco General Hospital and Trauma Center Rebuild Program 55823 2Jacobs Receives Contract for San Francisco General Hospital and Trauma Center Rebuild Program 55823 3Worlds Largest Medical Tourism and Global Healthcare Conference October 26 28th Announces Record Attendance Distinguished Speakers and Sponsors 55821 1Worlds Largest Medical Tourism and Global Healthcare Conference October 26 28th Announces Record Attendance Distinguished Speakers and Sponsors 55821 2
...uracy unknown until now, researchers from the Max ...n and the Bernstein Center for Computational Neuro...logist Maxim Volgushev from the Ruhr-Universität B...ls in the cerebral cortex decide to send out impul...ibility and speed with which these cells work cann...
...lete sequencing of human chromosome 17 and mouse c...tion of the genome of higher mammals, said a Baylo...in this effort reported in today,s issue of the jo...e that a mouse chromosome has been completely sequ...e chair and professor in the BCM department of mol...
...ch team at Uppsala University, Sweden has shown in...ica, that the size of the spot on a male collared ... defence system combats viruses such as avian infl... birds searching for a mate. , Evolutionary biolo...ls of a species differ in appearance and why the c...
Other Biology News:Why nerve cells work faster than the theory allows 2Why nerve cells work faster than the theory allows 3Why nerve cells work faster than the theory allows 4Mouse to man: The story of chromosomes 2Attractive birds more immune against bird flu 2
(Date:11/24/2009)... Nov. 24 /PRNewswire-Asia/ -- Shanghai Biolaxy ann...ation (SFDA) has approved the,investigational new ...t,(Nodlin), an innovative insulin formulation to t... initiate its first phase I clinical study. ,... blood glucose and poor,metabolism. The complicati...
(Date:11/24/2009)...FBI recently approved the Promega PowerPlex 16 HS ... generating DNA records for the National DNA Index...A (PRWEB) -- The FBI recently approved the Promega...ries participating in, or generating DNA records f...rently contains more than seven million profiles a...
(Date:11/24/2009)..., TORONTO, Nov. 24 /PRNewswire-FirstCall/ - H... Capital Inc., a leading provider of advanced lase...ch and fertility clinic markets, today reported op...ter ended September 30, 2009. , , Q3 2009 High... with $1.43 million in Q3 2008, - Gross profi...
(Date:11/24/2009).... 24, 2009 Arena Pharmac...that the company is scheduled to present at the Pi...December 1, 2009 at 11:30 a.m. Eastern Time (8:30 ... New York City. Jack Lief, Arena,s President and C... overview of the company, including its clinical d...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3
... revive Legislative support for his biofuels progr...cs, suggesting that GOP lawmakers are paying lip s...cks on state farmers, manufacturers, and entrepren...e, said every county in the state has more than 10...from a the bio-industry. , ,This should not be ab...
...arly-stage Wisconsin companies topped $100 million...t point to some interesting investment patterns. ,...led Risk Capital in Wisconsin: A Progress Report f...s , the Wisconsin Technology Council , and the st...ile the total amount of angel investing - $102.9 m...
...ng to add the Olympics to their list of great acco...ork infrastructure with more than just a third-par...look beyond national comparisons on Wi-Fi and into...ignificant investments in fiber optics. , , Look a...ing that third party Wi-Fi is the ultimate answer ...
Other Biology Technology:Breaking down Wisconsin's angel capital numbers 2Breaking down Wisconsin's angel capital numbers 3No network infrastructure, no Olympics, no nothing 2No network infrastructure, no Olympics, no nothing 3No network infrastructure, no Olympics, no nothing 4No network infrastructure, no Olympics, no nothing 5No network infrastructure, no Olympics, no nothing 6
Acridine Orange hemi(zinc chloride) salt from Sigma-Aldrich
Stains-All from Sigma-Aldrich
MutaGEL Parodontitis from Alpco Diagnostics
...ure (PCR, Exonuclease III digestion and rapid liga...The typical cloning efficiency using this method i...niversal - PCR amplicon can be cloned into any exp...ly>80% , High Expression Efficiency - Typically>66...
Biology Products: